ImmerseRx mNSCLC Immunotherapy
Augmented reality in mNSCLC
Archived App
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
An interactive learning tool using augmented reality to explore tumor immune evasion pathways in metastatic non-small cell lung cancer (mNSCLC). Users can manipulate 3D models and animations to understand immunotherapy targets and biomarker testing for treatment decisions.
What's New in ImmerseRx mNSCLC Immunotherapy
1.0.1
December 13, 2022
App Store listing updates.
Developer apps
FAQ
What is ImmerseRx mNSCLC Immunotherapy?
ImmerseRx mNSCLC Immunotherapy is an augmented reality learning tool designed to educate medical professionals on tumor immune evasion pathways in metastatic non-small cell lung cancer (mNSCLC) and how immunotherapy targets these pathways.
Who is ImmerseRx mNSCLC Immunotherapy for?
This app is created for medical oncologists, oncology nurse practitioners and physician assistants, pulmonologists, pathologists, and other healthcare professionals involved in the care of patients with mNSCLC.
What medical topics does ImmerseRx mNSCLC Immunotherapy cover?
It explores tumor immune evasion pathways in mNSCLC, such as the PD-1/PD-L1 pathway, how immunotherapy leads to tumor cell death, and the importance of biomarker testing for treatment decisions.
How can I interact with the 3D models in ImmerseRx mNSCLC Immunotherapy?
Users can pinch to zoom, scale, rotate, raise, or lower the 3D models. You can also walk around the objects to view animations up close for a comprehensive understanding.
Is ImmerseRx mNSCLC Immunotherapy free to use?
Yes, ImmerseRx mNSCLC Immunotherapy is available for free. It was supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.
What devices does ImmerseRx mNSCLC Immunotherapy support?
The app is supported on iPhone, iPad, and iPod devices, indicating compatibility across Apple's mobile ecosystem.
When was ImmerseRx mNSCLC Immunotherapy last updated?
The app was last updated on December 13, 2022, with version 1.0.1. This suggests it is a relatively new application.
Does ImmerseRx mNSCLC Immunotherapy include information on recent treatment approvals?
While the app explores key pathways, it notes that additional immunotherapy combinations were approved after its creation, such as cemiplimab plus chemotherapy and tremelimumab plus durvalumab plus chemotherapy.
